Compounds > phorbol 12,13-dibutyrate
Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and afimoxifene

phorbol 12,13-dibutyrate has been researched along with afimoxifene in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liskamp, RM; O'Brian, CA; Solomon, DH; Weinstein, IB1
Chen, ZH; Gopalakrishna, R; Gundimeda, U1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and afimoxifene

ArticleYear
Triphenylethylenes: a new class of protein kinase C inhibitors.
    Journal of the National Cancer Institute, 1986, Volume: 76, Issue:6

    Topics: Animals; Brain; Cells, Cultured; Estrogen Antagonists; Fibroblasts; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Rats; Stilbenes; Structure-Activity Relationship; Tamoxifen

1986
Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells.
    The Journal of biological chemistry, 1996, Jun-07, Volume: 271, Issue:23

    Topics: Animals; Antioxidants; Breast Neoplasms; Cattle; Cell Division; Cell Membrane; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Oxidative Stress; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rabbits; Receptors, Estrogen; Second Messenger Systems; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vitamin E

1996